Citius Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Citius Pharmaceuticals

14/02/2025 21:49

* Citius Pharmaceuticals Inc  CTXR.OQ  reported a quarterly
adjusted loss of $1.30​​ per share for the quarter ended
December 31, higher than the same quarter last year, when the
company reported EPS of $-1.50.  The mean expectation of
three analysts for the quarter was for a loss of 58 cents per
share. Wall Street expected results to range from $-1.48
to $1.00 per share.
    * Reported revenue was zero​; analysts expected $7.06
million. 
    * Citius Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.30​.
    * The company reported a quarterly loss of $9.77 million.
    * Citius Pharmaceuticals Inc shares had fallen by 32.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 361.3% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Citius
Pharmaceuticals Inc is $8.50 
This summary was machine generated from LSEG data February 14 at
09:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.58          -1.30          Missed
 Sep. 30 2024      -1.50          -1.59          Missed
 Jun. 30 2024      -1.25          -1.50          Missed
 Mar. 31 2024      -1.50          -1.25          Beat